Bahrain withdraws diabetes drug
Manama, September 27, 2010
Products containing the diabetes drug Rosiglitazone have been ordered off Bahrain's shelves by the Health Ministry.
It follows reports in Europe that pharmaceutical products such as Avandaryl, Avandamet and Avandia damage the heart and blood circulation.
The Pharmacy and Drugs Control Directorate has ordered these products off the shelves and is advising customers to stop using them. – TradeArabia News Service